Next-Day HIV Test Results Show Mixed Effects on Seeking Care

Adding rapid viral load testing did not improve overall linkage to care but sped up antiretroviral therapy initiation.

Feb. 3, 2026 at 4:15am

Got story updates? Submit your updates here. ›

A randomized clinical trial found that adding next-day, laboratory-based HIV viral load test results to standard-of-care testing did not improve overall linkage to care compared to standard-of-care test results alone. However, the intervention was associated with faster linkage to antiretroviral therapy (ART) among people living with HIV.

Why it matters

Improving linkage to HIV testing, treatment, and prevention services is crucial for reducing HIV transmission and improving health outcomes. This study provides insights into the potential benefits and limitations of rapid viral load testing in this context.

The details

Researchers randomly assigned 195 participants to receive either standard-of-care HIV antigen/antibody testing plus next-day viral load testing (intervention group) or standard-of-care testing alone (control group). The primary outcome was linkage to care, defined as having at least one conversation about HIV pre-exposure prophylaxis (PrEP) or ART with a healthcare professional within 12 weeks. While 55.1% of the intervention group were linked to care compared to 44.9% of the control group, the difference was not statistically significant. However, among people living with HIV, the intervention group had significantly faster linkage to ART, with 76.2% linked by day 50 compared to 25.0% in the control group.

  • The median turnaround time for HIV antigen/antibody test results was 6.4 hours.
  • The median turnaround time for viral load test results was 26.0 hours.

The players

Matthew M. Hamill

Lead author of the study, from the Johns Hopkins School of Medicine in Baltimore.

Got photos? Submit your photos here. ›

What they’re saying

“Further, more comprehensive, packaged interventions, such as rapid VL testing with immediate initiation or reinitiation of ART or PrEP, may be beneficial for HIV treatment and prevention.”

— Matthew M. Hamill

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

This study highlights the potential benefits of rapid viral load testing in speeding up linkage to antiretroviral therapy, but also the need for more comprehensive interventions to improve overall linkage to HIV care and prevention services.